Showing 1 - 4 results of 4 for search 'Barbara Volz', query time: 0.02s Refine Results
  1. 1
    Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors

    Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors by Kerstin Kapp, Barbara Volz, Detlef Oswald, Burghardt Wittig, Matthias Baumann, Manuel Schmidt

    Published 2019-12-01
    Get full text
    Article
  2. 2
    Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist

    Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist by Barbara Volz, Manuel Schmidt, Kerstin Heinrich, Kerstin Kapp, Matthias Schroff, Burghardt Wittig

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients

    Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients by Léa L. Volmer, Cansu E. Önder, Barbara Volz, Anjali R. Singh, Sara Y. Brucker, Tobias Engler, Andreas D. Hartkopf, André Koch

    Published 2023-09-01
    Get full text
    Article
  4. 4
    HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice

    HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice by Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow

    Published 2022-11-01
    Get full text
    Article

Search Tools: